Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.

Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E.

Am J Psychiatry. 2016 May 1;173(5):499-508.

Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.

Nasser AF, Henderson DC, Fava M, Fudala PJ, Twumasi-Ankrah P, Kouassi A, Heidbreder C.

J Clin Psychopharmacol. 2016 Apr;36(2):130-140.

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP.

Mol Psychiatry. 2015 Dec 8. doi: 10.1038/mp.2015.178. [Epub ahead of print]

The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study.

Fisher LB, Fava M, Doros GD, Alpert JE, Henry M, Huz I, Freeman MP

J Nerv Ment Dis. 2015 Oct;203(10):762-8. doi: 10.1097/NMD.0000000000000364.

Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder.

Targum SD, Wedel PC, Fava M.

J Psychiatr Res. 2015 Sep;68:392-6. doi: 10.1016/j.jpsychires.2015.04.024. Epub 2015 May 9.

Evaluation of opioid modulation in major depressive disorder.

Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M.

Neuropsychopharmacology. 2015 May;40(6):1448-55. doi: 10.1038/npp.2014.330. Epub 2014 Dec 18.

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Augmentation of a Nicotinic Acetylcholine Receptor Partial Agonist in Depression.

Fava M, Ramey T, Pickering E, Kinrys G, Boyer S, Altstiel L.

J Clin Psychopharmacol. 2015 Feb; 35 (1):51-56.

Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.

Cooper JA, Tucker VL, Papakostas GI.

J Psychopharmacol. 2014 Feb;28(2):118-24. doi: 10.1177/0269881113514878. Epub 2013 Dec 18.